extracellular
vesicl
ev
thought
import
cellcel
commun
elicit
extraordinari
interest
potenti
biomark
diseas
howev
quantit
method
enabl
elucid
mechan
underli
releas
describ
cellbas
assay
monitor
ev
releas
use
evenrich
tetraspanin
fuse
small
atpindepend
report
enzym
nanoluciferas
releas
ev
stabli
express
cell
line
monitor
compar
luciferas
activ
cultur
media
remain
cell
cell
releas
total
cellular
form
ev
hr
vari
cell
line
identifi
cellular
machineri
import
secret
ev
perform
screen
biolog
activ
chemic
cell
major
compound
significantli
affect
ev
releas
treat
cell
plecomacrolid
bafilomycin
concanamycin
known
inhibit
vatpas
dramat
increas
ev
releas
interestingli
alkal
endosom
lumen
use
weak
base
effect
suggest
phindepend
enhanc
ev
releas
vatpas
inhibitor
abil
quantifi
ev
small
sampl
enabl
futur
detail
studi
releas
kinet
well
chemic
genet
screen
defin
pathway
involv
ev
secret
extracellular
vesicl
ev
releas
cell
found
biolog
fluid
includ
urin
plasma
cerebrospin
fluid
saliva
etc
well
tissu
cultur
condit
media
ev
thought
mediat
cellcel
commun
may
carri
varieti
protein
lipid
rna
potenti
impact
target
cell
physiolog
propos
ev
modul
tumor
environ
allow
tumor
seed
growth
promot
angiogenesi
ev
also
implic
prionlik
spread
neuropathogen
protein
aggreg
sever
neurodegen
diseas
certain
virus
bacteria
hepat
viru
herpesviru
hiv
uropathogen
e
coli
may
use
cellular
pathway
ev
biogenesi
extracellular
releas
recent
studi
mani
laboratori
focus
explor
util
ev
isol
directli
biolog
fluid
diseas
biomark
final
ev
also
develop
therapeut
agent
capabl
deliv
drug
specif
tissu
organ
bodi
ev
produc
least
two
distinct
way
fusion
endosom
multivesicular
bodi
mvb
plasma
membran
releas
intralumin
vesicl
form
exosom
wherea
direct
outward
bud
plasma
membran
gener
ectosom
also
refer
microvesicl
base
origin
ev
number
protein
well
establish
marker
among
tetraspanin
character
four
membran
span
helic
includ
notabl
predominantli
local
intralumin
vesicl
ilv
late
endosom
mvb
thu
enrich
exosom
cytoplasm
protein
includ
member
endosom
sort
complex
requir
transport
escrt
machineri
syntenin
certain
chaperon
also
enrich
ev
addit
varieti
rna
present
thought
carri
signal
involv
cellcel
commun
sever
packag
mirna
shown
exert
specif
biolog
effect
support
notion
ev
cargo
activ
select
mechanist
understand
cargo
select
packag
ev
ev
releas
regul
import
futur
progress
area
ev
small
rang
size
diamet
make
difficult
monitor
use
lightbas
method
studi
ev
depend
effici
collect
cell
cultur
media
biolog
fluid
use
high
speed
centrifug
precipitationbas
method
cultur
cell
produc
small
quantiti
ev
analyt
studi
tend
requir
larg
volum
condit
media
cell
cultur
one
day
may
contamin
materi
associ
cell
injuri
death
moreov
typic
use
isol
procedur
ineffici
extens
loss
preclud
reproduc
quantit
yield
thu
better
method
need
quantifi
ev
small
sampl
facilit
chemic
genet
screen
elucid
cell
biolog
mechan
involv
ev
biogenesi
identifi
strategi
modul
ev
product
develop
new
cellbas
assay
system
quantit
ev
releas
high
sensit
use
stabl
cell
line
express
fuse
nanoluciferas
report
use
assay
system
screen
set
known
biolog
activ
compound
reveal
pathway
impact
ev
releas
cell
thermo
fisher
cat
purchas
american
type
cultur
collect
manassa
va
cell
transfect
appropri
plasmid
stabl
transfect
select
use
zeocin
thermo
cat
dmem
gibco
fetal
bovin
serum
atlanta
biolog
nanoglo
luciferas
assay
system
purchas
promega
cat
antibodi
use
studi
list
tabl
plasmid
construct
plasmid
nluc
carri
nanoluciferas
cdna
gift
promega
cat
nluc
gene
amplifi
use
pcr
upstream
hatag
along
appropri
clone
site
express
either
solubl
cytoplasm
protein
hanl
fusion
ntermin
end
gene
plasmid
thermo
fisher
cat
backbon
cell
express
hanl
grown
media
without
tetracyclin
induc
tetracyclin
overnight
also
compar
cell
continu
maintain
media
contain
low
concentr
tetracyclin
found
differ
two
paradigm
studi
maintain
cell
media
contain
tet
maintain
cell
constitut
state
typic
cell
per
well
plate
plate
need
condit
test
cell
attach
cell
wash
twice
media
remov
previous
releas
ev
fresh
media
contain
appropri
drug
indic
figur
ad
cell
media
per
well
effect
drug
measur
indic
durat
typic
hour
end
treatment
condit
media
remov
label
tube
centrifug
minut
remov
larg
cell
debri
supernat
media
ev
collect
fresh
tube
cell
remain
media
plate
triton
ad
final
permeabil
cell
releas
content
total
confirm
triton
alter
nluc
activ
hanl
sampl
see
fig
media
ev
sampl
dilut
total
sampl
blank
media
transfer
plate
costar
well
contain
sampl
nanoglo
luciferas
assay
promega
cat
reagent
prepar
per
manufactur
instruct
ad
luminesc
measur
immedi
reagent
addit
use
micropl
reader
biotek
synergi
hybrid
background
luminesc
mediaonli
blank
also
measur
within
plate
sampl
measur
duplic
triplic
averag
plot
obtain
unbias
quantit
ev
variou
sampl
ratio
luminesc
media
ev
total
cell
lystat
report
term
fraction
releas
precipit
ev
condit
media
rd
volum
peg
prepar
pb
ad
condit
media
final
concentr
peg
incub
overnight
mixtur
centrifug
minut
pellet
resuspend
pb
immunofluoresc
experi
cell
plate
untreat
coverslip
circl
separ
well
plate
cell
fix
paraformaldehyd
pb
minut
room
temperatur
move
fresh
well
contain
pb
fix
cell
block
permeabil
pb
contain
goat
serum
saponin
block
coverslip
incub
primari
antibodi
dilut
made
block
solut
follow
wash
pb
coverslip
incub
secondari
antibodi
dilut
made
block
solut
follow
wash
pb
coverslip
given
final
rins
pb
mount
clean
glass
slide
gelvatol
allow
set
overnight
imag
collect
use
nikon
spin
disk
confoc
microscop
equip
ccd
camera
nikon
element
softwar
immunoblot
experi
cell
seed
densiti
cell
per
well
plate
growth
medium
condit
media
collect
subject
peg
precipit
describ
cell
collect
pb
tube
pellet
minut
cell
pellet
lyse
hypoton
lysi
buffer
contain
trishcl
ph
sodium
dodecyl
sulfat
sd
proteas
inhibitor
cocktail
roch
unitsml
benzonas
sigma
minut
room
temperatur
sdspage
load
dye
antiha
blot
without
blot
ad
sampl
boil
minut
sampl
separ
sdspage
blot
onto
nitrocellulos
membran
membran
block
nonfat
dri
milk
tb
tween
follow
incub
primari
secondari
antibodi
dilut
wash
step
blot
develop
use
chemiluminesc
imag
biorad
chemidoc
band
quantifi
use
biorad
imagelab
softwar
develop
high
sensit
assay
detect
ev
releas
limit
number
cell
short
time
small
volum
cultur
media
fuse
smallest
avail
report
luciferas
known
nanoluciferas
nluc
addit
fuse
nluc
also
develop
solubl
nluc
report
monitor
nonspecif
leakag
cellular
content
result
cell
injuri
death
nluc
luciferas
base
natur
occur
monomer
luciferas
deepsea
shrimp
oplophoru
sp
nluc
util
coelenterazin
analog
furimazin
substrat
produc
bright
glowtyp
luminesc
atpindepend
reaction
nluc
engin
use
varieti
applic
requir
quantit
sensit
measur
enabl
antibodybas
monitor
fusion
protein
introduc
hemagglutinin
ha
tag
nterminu
nluc
gener
hanl
fig
sinc
gyxxfmotif
near
cterminu
bind
clathrin
adaptor
protein
involv
sort
gfp
fusion
nterminu
success
previou
studi
fuse
hanl
cytoplasm
nterminu
gener
fig
hanl
clone
tetracyclin
tet
induc
promot
transfect
cell
select
stabl
cell
line
first
examin
express
fusion
protein
tetinduc
human
embryon
kidney
cell
immunoblot
fig
express
hanl
induc
ad
tet
cell
line
compar
express
cell
incub
overnight
high
concentr
tet
cell
grown
continu
presenc
low
concentr
tet
three
passag
gener
tetinduc
express
hanl
affect
rate
cell
growth
cell
number
rel
uninduc
control
data
shown
immunoblot
cell
lysat
reveal
express
induc
level
compar
less
endogen
fig
immunoblot
hanl
sampl
ha
show
hanl
strongli
induc
respons
tet
fig
quantit
band
fig
show
tetinduc
sampl
express
addit
band
band
fig
correspond
observ
rel
quantit
endogen
feasibl
sinc
endogen
migrat
multipl
band
fig
fig
similar
result
obtain
use
tetinduc
cell
fig
next
examin
hanl
local
immunofluoresc
confoc
microscopi
fig
compar
distribut
hatag
late
endosomelysosom
protein
cell
express
hasign
distribut
similarli
intracellular
organel
small
proport
also
observ
plasma
membran
expect
endogen
overexpress
contrast
ha
stain
hanl
express
cell
diffus
present
throughout
cytoplasm
distinct
confirm
cytoplasm
distribut
expect
express
cell
also
mostli
coloc
fig
determin
whether
use
marker
ev
releas
next
test
releas
detect
condit
media
associ
ev
ad
polyethylen
glycol
peg
condit
cell
media
describ
earlier
measur
nluc
activ
peg
solubl
insolubl
fraction
fig
although
peg
precipit
select
ev
method
provid
simpl
robust
method
quantit
collect
evassoci
condit
media
hanl
sampl
nearli
nluc
activ
found
peg
solubl
fraction
sampl
nluc
activ
found
peg
insolubl
fraction
consist
presenc
ev
confirm
immunoblot
peg
pellet
antibodi
fig
peg
pellet
hanl
cell
media
singl
band
endogen
detect
molecular
weight
band
wherea
deriv
sampl
addit
band
higher
molecular
weight
band
observ
consist
addit
recoveri
ha
tag
proport
signal
band
associ
endogen
similar
cell
lysat
shown
fig
ev
shown
fig
suggest
tag
endogen
protein
incorpor
similarli
ev
togeth
local
late
endosom
lysosom
conclud
nluc
activ
use
monitor
ev
associ
quantit
track
ev
releas
express
cell
measur
nluc
activ
condit
media
well
total
nluc
activ
express
cell
allow
us
report
ev
releas
compar
term
ratio
extracellular
total
nluc
activ
fraction
releas
collect
condit
media
time
indic
replac
volum
media
contain
triton
extract
remain
cell
see
fig
show
effect
triton
nluc
activ
hanl
cell
small
portion
total
cellular
releas
ev
hr
collect
period
fig
insight
fraction
releas
ev
cytoplasm
protein
vari
among
differ
cell
line
gener
character
cell
stabli
express
local
endosom
cell
fig
fig
data
shown
interestingli
differ
cell
line
exhibit
differ
level
ev
releas
period
fig
cell
show
fraction
releas
cell
releas
total
cellular
result
underscor
util
assay
system
defin
ev
product
differ
type
cell
use
stabli
transfect
cell
experi
studi
import
clue
understand
ev
biogenesi
modul
come
monitor
kinet
ev
releas
given
ineffici
current
exosom
isol
method
ev
releas
howev
mostli
studi
singl
prolong
collect
time
without
time
resolut
specif
normal
parent
cell
model
system
well
suit
monitor
kinet
ev
releas
measur
fraction
releas
ev
associ
cytoplasm
hanl
differ
time
initi
collect
condit
media
cell
extract
collect
use
measur
nluc
activ
time
cours
releas
show
low
initi
amount
nluc
activ
media
roughli
cellular
steadili
increas
reach
fraction
releas
approxim
fivefold
increas
demonstr
sensit
model
system
detect
chang
ev
releas
importantli
baselin
condit
ev
continu
releas
cell
express
hanl
amount
nluc
present
media
roughli
cellular
hanl
remain
unchang
hour
fig
base
fact
extracellular
hanl
precipit
ad
peg
fig
interpret
presenc
reflect
form
cell
membran
damag
like
associ
media
chang
wash
begin
experi
exist
method
bulk
ev
isol
analysi
creat
bottleneck
effort
advanc
understand
ev
biogenesi
screen
compound
modul
specif
cellular
machineri
begin
assess
involv
differ
cellular
machineri
releas
ev
treat
cell
express
hanl
variou
compound
hr
condit
media
collect
end
treatment
nluc
activ
measur
fig
note
screen
paradigm
suitabl
identifi
compound
stimul
ev
releas
longer
ev
collect
time
andor
cell
releas
high
level
ev
like
need
uncov
inhibitor
ev
biogenesi
follow
five
group
compound
test
ion
balanc
perturb
oubain
inhibit
sodiumpotassium
atpas
amilorid
block
sodium
channel
thapsigargin
inhibit
er
calcium
channel
serca
activ
endosom
calcium
channel
lysosom
perturb
bafilomycin
inhibit
vatpas
proton
pump
chloroquin
lysosomotrop
alkal
agent
cytoskeleton
perturb
nocodazol
depolymer
microtubul
latrunculin
block
actin
polymer
jasplakinolid
induc
actin
polymer
lipid
perturb
wortmannin
inhibit
kinas
apilimod
inhibit
amiodaron
accumul
lbpa
endosom
methyl
reduc
cellular
cholesterol
inhibit
lysosom
cholesterol
export
bisphosphon
acid
abpa
inhibit
acid
sphingomyelinas
inhibit
neutral
sphingomyelinas
perturb
inhibit
aaa
atpas
inhibit
bortezomib
inhibit
proteasom
everolimu
inhibit
fig
show
effect
compound
extracellular
nluc
releas
cell
express
hanl
none
compound
test
signific
effect
extracellular
nluc
activ
hanl
sampl
fig
show
test
compromis
cell
integr
compound
test
also
chang
extracellular
nluc
releas
cell
express
significantli
increas
indic
enhanc
ev
biogenesi
andor
releas
notabl
larg
increas
releas
ev
trigger
treat
cell
bafilomycin
explor
compound
modul
ca
homeostasi
also
increas
releas
ca
channel
endolysosom
membran
implic
control
releas
endolysosom
ca
connect
exosom
releas
treat
cell
activ
doubl
ev
releas
consist
earlier
report
treat
cell
thapsigargin
releas
er
ca
inhibit
sarcoendoplasm
reticulum
ca
atpas
serca
also
increas
ev
releas
similar
previou
observ
result
suggest
increas
ca
multipl
sourc
enhanc
ev
releas
also
observ
compound
affect
actin
cytoskeleton
microtubul
increas
ev
releas
stabil
actin
filament
jasplakinolid
inhibit
actin
polymer
latrunculin
increas
ev
releas
screen
potenti
reliev
restrict
exocytosi
enhanc
bleb
plasma
membran
expect
transport
endosomesmvb
along
microtubul
might
import
exocytosi
ev
releas
lack
effect
nocodazol
support
role
time
cours
measur
studi
requir
determin
exact
role
cytoskeleton
ev
biogenesi
andor
releas
none
lipid
perturb
test
caus
signific
chang
releas
specif
deplet
cellular
cholesterol
increas
effect
ev
releas
previous
report
stimulatori
well
inhibitori
role
ev
biogenesi
anoth
lipid
perturb
apilimod
shown
caus
increas
ev
releas
treatment
small
stimulatori
effect
magnitud
may
obviou
time
cours
screen
inhibitori
effect
drug
previous
shown
act
treatment
also
obviou
screen
one
possibl
explan
would
expect
inhibit
exocytosi
exist
mvb
also
possibl
overexpress
may
diminish
sensit
ev
biogenesi
machineri
inhibitori
drug
inhibitor
vcp
proteasom
also
signific
effect
concentr
test
final
everolimu
rapalog
inhibitor
lead
hyperactiv
akt
signal
reproduc
enhanc
ev
releas
fig
saw
strike
increas
ev
releas
follow
treatment
bafilomycin
inhibit
vatpas
proton
pump
therebi
allow
lumen
ph
lysosom
rise
second
minut
observ
increas
releas
consist
previou
report
bafilomycin
enhanc
variou
type
ev
releas
effect
attribut
ph
neutral
effect
inhibit
vatpas
curious
howev
found
treat
cell
chloroquin
rapidli
neutral
lumen
ph
weak
base
effect
releas
set
explor
basi
strike
dichotomi
first
ask
whether
bafilomycin
enhanc
ev
releas
untransfect
cell
use
tradit
ev
isol
immunoblot
techniqu
treat
cell
vehicl
bafilomycin
hr
examin
accumul
marker
protein
includ
flotillin
syntenin
pegconcentr
ev
bafilomycin
treatment
robustli
increas
releas
evassoci
protein
consist
vel
velcad
ever
everolimu
data
compar
two
waysfirst
use
twoway
anova
tukey
multipl
comparison
test
compar
effect
drug
within
sampl
hanl
sampl
bafilomycin
significantli
effect
increas
ev
releas
control
p
cq
p
second
also
compar
individu
drug
effect
hanl
sampl
use
multipl
ttest
reveal
bafilomycin
latrunculin
significantli
increas
ev
releas
p
valu
baf
lata
broad
base
increas
ev
fig
result
demonstr
increas
ev
releas
follow
treatment
bafilomycin
gener
phenomenon
specif
cell
overexpress
next
understand
whether
differ
effect
vatpas
inhibitor
alkal
agent
ev
releas
might
due
differ
effect
total
amount
cellular
compar
level
immunoblot
cell
lysat
pegconcentr
ev
treatment
bafilomycin
chloroquin
fig
fig
cellassoci
increas
compar
hour
either
bafilomycin
chloroquin
suggest
interfer
normal
lysosom
activ
howev
ev
isol
cell
show
treatment
bafilomycin
increas
evassoci
far
dramat
treatment
chloroquin
order
test
whether
enhanc
releas
caus
bafilomycin
specif
ev
secret
examin
effect
secret
protein
pass
classic
secretori
pathway
intersect
ev
biogenesi
pathway
specif
examin
secret
nanoluciferas
secnl
model
protein
classic
secret
develop
fuse
secret
signal
nanoluciferas
fig
extracellular
nluc
activ
measur
cell
express
secnl
addit
bafilomycin
extracellular
intracellular
ratio
fraction
releas
secnl
increas
within
untreat
condit
greatli
inhibit
bafilomycin
extracellular
releas
enhanc
bafilomycin
bafilomycin
previous
observ
interfer
classic
secret
result
togeth
result
show
effect
bafilomycin
releas
cytoplasm
hanl
demonstr
stimulatori
effect
bafilomycin
specif
ev
protein
releas
attribut
nonspecif
releas
cellular
protein
result
die
cell
sinc
mvb
either
fuse
lysosom
content
degrad
plasma
membran
releas
ilv
exosom
posit
block
lysosom
function
compound
would
shed
light
trigger
respons
enhanc
ev
releas
use
express
cell
first
test
effect
anoth
inhibitor
vatpas
function
concanamycin
well
weak
base
ammonium
chlorid
concanamycin
stimul
ev
releas
level
compar
seen
bafilomycin
ammonium
chlorid
effect
ev
releas
fig
test
whether
accumul
undegrad
protein
within
lysosom
might
promot
releas
treat
cell
lysosom
proteas
inhibitor
leupeptin
pepstatin
measur
extracellular
nluc
inhibitor
either
singli
combin
also
effect
releas
suggest
accumul
undegrad
protein
endolysosom
strong
trigger
ev
releas
fig
understand
whether
stimulatori
effect
vatpas
inhibitor
depend
chang
organel
ph
treat
cell
bafilomycin
togeth
ammonium
chlorid
chloroquin
stimul
releas
vatpas
inhibit
unaffect
alkal
agent
fig
suggest
inhibit
vatpas
alon
necessari
suffici
promot
enhanc
releas
report
develop
facil
cellbas
assay
system
sensit
quantifi
releas
ev
small
volum
condit
cultur
media
distinct
phenomenon
nonspecif
cell
lysi
fuse
small
atpindepend
luciferas
endolysosom
tetraspanin
report
ev
addit
luciferas
local
cytoplasm
use
report
nonspecif
releas
cytoplasm
due
damag
injuri
cell
enabl
direct
determin
ev
marker
releas
follow
differ
cell
treatment
use
marker
establish
differ
cultur
cell
line
differ
ev
product
also
observ
ev
constitut
continu
releas
sever
hour
time
period
distinct
cytosol
leakag
system
enabl
first
pass
broadspectrum
screen
use
compound
known
mechanist
target
pave
way
futur
delin
mechan
ev
biogenesi
import
find
screen
import
vatpas
activ
regul
ev
releas
choic
luciferas
nanoluciferas
nluc
small
size
high
stabil
bright
glowtyp
luminesc
stabl
min
nluc
luminesc
atpindepend
time
brighter
firefli
renilla
luciferas
nluc
disulfid
bind
therefor
well
suit
express
cytoplasm
cytoplasm
extens
transmembran
protein
distinct
anoth
small
bright
luciferas
deriv
gaussia
mani
disulfid
bond
therefor
better
suit
express
lumen
extens
transmembran
protein
luciferasebas
track
exosom
ev
previous
explor
danzer
et
al
use
split
gaussia
luciferas
system
investig
packag
releas
specif
aggreg
cargo
within
exosom
cultur
cell
requir
aggreg
step
limit
quantit
interpret
ev
releas
other
use
membran
local
version
gaussia
luciferas
monitor
ev
vivo
manuscript
prepar
anoth
report
nluc
fuse
ctermin
end
confirm
gener
util
tracer
track
membran
ev
vitro
vivo
howev
ctermin
fusion
tracer
may
perturb
function
gyxxf
sort
signal
present
cterminu
proofof
concept
use
system
pharmacolog
screen
test
effect
treat
nluc
marker
express
cell
compound
known
perturb
ionic
homeostasi
lysosom
function
cytoskelet
structur
dynam
lipid
metabol
proteostasi
screen
paradigm
short
ev
collect
time
better
suit
identifi
compound
enhanc
ev
releas
result
screen
demonstr
inhibitor
vatpas
bafilomycin
concanamycin
profound
stimul
ev
releas
demonstr
util
facil
assay
system
drug
genet
screen
howev
short
ev
collect
time
unabl
valid
effect
previous
describ
inhibitor
ev
biogenesi
potenti
incub
period
shorter
report
literatur
need
observ
effect
overexpress
may
enhanc
ev
biogenesi
obscur
effect
inhibitori
drug
increas
durat
drug
treatment
ev
collect
may
make
assay
suitabl
screen
inhibitor
ev
biogenesi
find
bafilomycinstimul
ev
releas
agreement
earlier
observ
show
increas
secret
lysosom
enzym
upon
treatment
bafilomycin
bafilomycinmedi
stimul
ev
releas
also
observ
recent
paper
wherein
also
shown
hela
cell
exosom
retain
plasma
membran
action
tetherin
author
also
demonstr
treatment
cell
bafilomycin
interrupt
cholesterol
traffick
lead
cholesterol
accumul
endosom
exosom
studi
found
compound
increas
decreas
cholesterol
alter
ev
releas
suggest
accumul
endosom
cholesterol
like
trigger
increas
ev
releas
cell
small
increas
observ
exosom
releas
treatment
either
bafilomycin
chloroquin
importantli
system
unlik
bafilomycin
treatment
ev
releas
could
increas
either
alkal
endosom
lumen
inhibit
lysosom
proteas
suggest
neither
lumen
ph
endosom
lysosom
degrad
capac
respons
increas
exocytosi
vivo
studi
c
elegan
reveal
vatpas
mediat
apic
secret
exosom
contain
hedgehogrel
protein
might
vatpas
inhibit
bafilomycin
concanamycin
stimul
ev
releas
ev
biogenesi
influenc
perturb
variou
step
includ
gener
intralumen
vesicl
endosom
traffick
motil
endosom
well
exocytosi
possibl
vatpas
complex
might
somehow
respons
increas
exocytosi
bafilomycin
concanamycin
bind
v
atpas
complex
presum
interfac
aand
csubunit
sit
lipid
bilay
bind
inhibitor
thought
interfer
helic
swivel
requir
proton
transloc
thought
associ
dissoci
v
atpas
complex
v
complex
key
regulatori
step
mani
cellular
pathway
includ
exocytosi
synapt
vesicl
v
v
atpas
complex
shown
recruit
key
signal
machineri
mtor
kinas
sens
endolysosom
function
gener
appropri
respons
regul
protein
synthesi
cholesterol
transport
review
kozik
et
al
found
import
role
vatpas
clathrinco
vesicl
format
johnson
et
al
found
lower
vatpas
activ
coincid
local
endolysosom
cell
peripheri
could
increas
probabl
exocytosi
ev
releas
merkulova
et
al
map
sever
proteinprotein
interact
subunit
cytoplasm
v
atpas
complex
found
eg
rabconnectin
involv
exocytosi
vatpas
found
requir
invas
growth
metastasi
breast
cancer
suggest
vatpas
rab
gtpase
implic
exosom
biogenesi
function
connect
clear
understand
whether
bafilomycin
increas
decreas
abund
v
v
holoenzym
role
associ
exocyt
machineri
illumin
mode
action
exocytosi
mvb
target
lumen
cargo
protein
either
degrad
fusion
lysosom
extracellular
releas
fusion
plasma
membran
reason
hypothes
vatpas
may
contribut
gener
proteostasi
abil
sens
endosom
lysosom
function
order
shunt
undegrad
potenti
damag
protein
cell
exocytosi
support
idea
observ
c
elegan
neuron
stress
result
expuls
bolu
protein
aggreg
exocytosi
autophagi
protein
shown
dissoci
subunit
v
v
atpas
complex
promot
exosom
product
observ
suggest
reduc
vatpas
function
due
accumul
protein
aggreg
endosomeslysosom
may
lead
extracellular
releas
potenti
pathogen
protein
aggreg
turn
could
spread
diseas
patholog
brain
work
need
delin
underli
mechan
vatpas
facilit
ev
releas
studi
develop
novel
model
system
quantit
assay
small
amount
ev
demonstr
util
model
system
screen
compound
affect
pathway
import
cargoselect
packag
exocytosi
event
lead
ev
releas
use
novel
model
system
identifi
vatpas
import
regul
ev
secret
given
bright
luminesc
nluc
predict
construct
present
paper
may
also
success
use
vivo
surfac
well
deep
tissu
previous
demonstr
support
inform
tabl
list
antibodi
use
studi
ev
isol
hanl
express
cell
ultracentrifug
minut
ev
pellet
resuspend
pb
contain
deterg
triton
nluc
luminesc
measur
differ
obviou
sampl
demonstr
addit
nluc
sampl
affect
luminesc
pdf
nluc
luminesc
measur
condit
cultur
media
hanl
cell
treat
without
baf
bafilomycin
baf
either
cotreat
ammcl
cotreat
ammonium
chlorid
ammcl
alkal
agent
differ
observ
baf
sampl
without
ammonium
chlorid
cotreat
result
show
alkal
agent
influenc
increas
ev
releas
due
vatpas
inhibitor
pdf
